Three longevity peptides on TikTok: hype vs. actual evidence

What did @research_stack actually say?

The creator named three peptides as the "best for anti-aging": MOTS-c (called "Moz. C."), GHK-Cu (a copper peptide), and Epithalon (called "the pitilong"). The claims escalated quickly. MOTS-c supposedly gives you "the same energy, metabolism, and recovery you had at 25." GHK-Cu "controls 4,000 of your genes" and makes your skin, hair, and healing revert to pre-30 levels. Epithalon "rebuilds the caps on your DNA" and caused elderly subjects to "dramatically increase their lifespan." Each claim is specific enough to fact-check, which is good. The problem is that specificity and accuracy are not the same thing.

Does the science back this up?

Partially, and less than the video implies. GHK-Cu has the strongest research foundation of the three. Lunde and Goren (2019, Journal of Aging Science) and Pickart's extensive work do show GHK-Cu influences gene expression at scale, and the "4,000 genes" figure traces to real transcriptomic data. MOTS-c is a genuine mitochondrial-derived peptide with legitimate preclinical interest. Lee et al. (2015, Cell Metabolism) identified it as a regulator of metabolic homeostasis in mice. Epithalon research comes almost entirely from Russian scientists, particularly Khavinson, working with small samples and limited independent replication. The "dramatically increase lifespan" claim for humans is not supported by peer-reviewed evidence most Western journals would accept.

What did they get wrong (or right)?

The GHK-Cu gene regulation claim is defensible in outline, though "controls" is too strong a word for what is more accurately described as modulation. The creator deserves credit for getting the approximate number from actual research rather than thin air. Where things go wrong: claiming MOTS-c replicates your physiology "at 25" is not a finding from any published human trial. That is marketing language dressed as science. The telomere angle on Epithalon is also muddled. Epithalon has been studied in relation to telomerase activity, but the mechanism described, literally "rebuilding caps," misrepresents how telomere biology works. Telomeres shorten through replication; Epithalon may influence telomerase, not reconstruct existing telomeres. The creator also implies the 60% GHK-Cu decline figure is well-established. It is cited but not consistently replicated across populations.

• Accurate in outline: GHK-Cu gene expression influence
• Overstated: MOTS-c restoring "25-year-old" physiology in humans
• Mechanistically wrong: Epithalon "rebuilding" telomere caps
• Misleading framing: Epithalon human lifespan data presented as settled science

What should you actually know?

These are research-stage compounds. MOTS-c has no approved human clinical trials with longevity endpoints. GHK-Cu has legitimate cosmetic and wound-healing applications but the systemic anti-aging claims are ahead of the data. Epithalon sits in a peculiar position: the research exists, but it is concentrated in one research group, published largely in Russian journals, and has not been reproduced at scale by independent teams. That does not make it fake. It makes it unverified. Anyone consuming content like this should ask one question: is the evidence from human trials, or from cells and rodents? For all three peptides, the honest answer is mostly the latter. These compounds may matter eventually. They may not. Presenting them as certainties is a disservice to the audience, regardless of how many hashtags say "educational."

Is there a safety concern here?

The video does not discuss side effects, drug interactions, or the regulatory status of these peptides. In the United States, MOTS-c, GHK-Cu, and Epithalon are not FDA-approved drugs. Epithalon in particular is not available as a regulated pharmaceutical product in most Western markets. Sourcing these compounds outside of a supervised clinical context carries real risks, including contamination, inaccurate dosing, and unknown interactions. The creator's disclaimer says "not medical advice," but the framing throughout is persuasive and directive. That gap between legal disclaimer and actual message content is where audiences get hurt.